It has already been proved that ISGylation as a novel ubiquitin-like modifier can control exosomes production [117] and syndecan-syntenin-ALIX plays a key role in the biogenesis of exosomes [118], which can also be targeted in NSCLC. This evidence concerns the gene PDCD6IP and non-small cell lung carcinoma.